Bitcoin investor MicroStrategy’s $250 million preferred-stock offering may price at a discount to its face value of $100 per share due to apparent insufficient demand for the deal.

Technological innovations in steam power, electricity and microprocessors drove the first industrial revolution.

Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...

In a report released today, Betty Jiang from Barclays maintained a Hold rating on APA (APA – Research Report), with a price target of $27.00.

Barclays analyst Benjamin Budish maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $95.00. The ...

In a report released today, Ramsey El Assal from Barclays maintained a Buy rating on Automatic Data Processing (ADP – Research Report), with a ...

Barclays analyst Alex Scott maintained a Hold rating on Progressive (PGR – Research Report) today and set a price target of $261.00. The ...

Barclays analyst Dan Levy maintained a Buy rating on General Motors (GM – Research Report) today and set a price target of $70.00. The ...

Barclays lowered the firm’s price target on Nasdaq (NDAQ) to $95 from $96 and keeps an Overweight rating on the shares post the Q4 report. The ...

Broadcom rose 5% on Thursday as Meta Platforms announced plans to increase use of chips designed with Broadcom.

Equities researchers at DA Davidson increased their FY2025 EPS estimates for Pacific Premier Bancorp in a research report ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...